rawfin.tv
Eli Lilly Invests in AI Clinical Assistant Abridge, Expanding Workflows
TechnologytechAI Generated

Eli Lilly Invests in AI Clinical Assistant Abridge, Expanding Workflows

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Abridge, an AI clinical assistant company, has secured a strategic investment from pharmaceutical giant Eli Lilly. The funding will support the expansion of Abridge's platform into payer and research workflows.

Healthcare TechAIBiotechnologyLLY

Related Articles

Amazon's AI Business Reaches $25 Billion Run Rate

Amazon's AI Business Reaches $25 Billion Run Rate

tech
OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

OpenAI Nears $30 Billion Funding Round at $1.25 Trillion Valuation

tech
Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

tech
Apple Partners with Meta to Run 816-Billion AI Model Locally

Apple Partners with Meta to Run 816-Billion AI Model Locally

tech